Today's News |
|
Coronavirus vaccine from Oxford and AstraZeneca shows positive response in early trial
Monday, July 20, 2020
Vancouver, BC, July 20, 2020--A potential coronavirus vaccine developed by Oxford University in the U.K. with pharmaceutical giant AstraZeneca has produced a promising immune response in a large, early-stage human trial, according to newly released data published Monday in the medical journal The Lancet. The experimental vaccine ChAdOx1 nCoV-19 combines genetic material from the coronavirus with a modified adenovirus that is known to cause infections in chimpanzees.
|
Copyright © T-NET. All Rights Reserved. | https://www.bctechnology.com |
|